Search results

  1. M

    U.S. Secretary of Commerce Explains How the Administration Brought Down GLP-1 Prices in the U.S.

    The USA pays higher drug prices because until recently (Passage of the 2022 Inflation Reduction Act) the US government was prohibited from negotiating with drug companies for lower prices. The 2022 act passed almost exclusively along party lines with democrates supporting it and republicans...
Back
Top